AN2 Therapeutics, Inc. — Director's Dealing 2024

Nov 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AN2 Therapeutics, Inc. (ANTX)
CIK: 0001880438
Period of Report: 2024-11-18

Reporting Person: Easom Eric (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-18	Common Stock	P	50000	$0.9994	Acquired	1065766	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	101130	Direct
Common Stock	97058	Indirect
Common Stock	97058	Indirect

Footnotes

F1: Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.

F2: Includes 99,000 restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of each such date.

F3: Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.

F4: Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.